Astrazeneca Pharma India standalone net profit rises 5.64% in the December 2025 quarter
Sales rise 38.90% to Rs 611.57 crore
Net profit of Astrazeneca Pharma India rose 5.64% to Rs 32.59 crore in the quarter ended December 2025 as against Rs 30.85 crore during the previous quarter ended December 2024. Sales rose 38.90% to Rs 611.57 crore in the quarter ended December 2025 as against Rs 440.29 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var.Sales611.57440.29 39 OPM %7.3317.49 -PBDT48.9084.64 -42 PBT45.0675.57 -40 NP32.5930.85 6Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Feb 12 2026 | 9:15 AM IST